Diabetes

FDA panel has tie vote on new type 1 diabetes drug

(HealthDay)—A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.

Alzheimer's disease & dementia

Biogen calls criticism of Alzheimer's drug 'misinformation'

Biogen Inc. fought back against criticism of the unusual circumstances that led to the U.S. approval of its Alzheimer's drug Aduhelm, saying in an open letter it has been the subject of "extensive misinformation and misunderstanding."

Cardiology

Challenges in acute heart attack care continue post COVID-19

A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart attack patients. However, during the COVID-19 pandemic certain obstacles—including the need for COVID-19 screening, associated ...

Oncology & Cancer

Harms reporting is inconsistent across organ cancer guidelines

A review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures is inconsistent across cancer types and at each stage of the screening process. The ...

Neuroscience

New guidance approves AI-derived software for stroke assessments

Two cutting-edge artificial intelligence tools used to assist the diagnosis of strokes have been approved by the National Institute for Health and Care Excellence (NICE). The team of national experts, which includes researchers ...

Vaccination

J&J seeks US clearance for COVID-19 vaccine booster doses

Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.

Diseases, Conditions, Syndromes

Virus pushes science and its controversies centre stage

Hydroxychloroquine, double-blind studies, convalescent plasma, herd immunity—the coronavirus pandemic has thrust the language of science into public view as never before.

page 2 from 3